跳至主要内容
临床试验/NL-OMON23599
NL-OMON23599尚未招募不适用

Routine obstetric medications and maternal heart rate variability

Philips Electronics Nederland B.V.0 个研究点目标入组 61 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
61

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Aged 18 years and above
  • -Gestational age 23 5/7 to 33 6/7 weeks upon admission
  • -Yet to receive second dose of antenatal corticosteroids
  • -Proficient in Dutch or English

排除标准

  • -History of cardiovascular disease, specifically severe arrhythmia and congenital heart disease
  • -Cushing’s disease
  • -Known allergies for hard plastic (like in sport watches) or elastic band material.
  • -Presence of wounds, injuries or infectious diseases on the skin where the wrist-wearable device will be placed.
  • -Tattoo on top of wrist (where sensor should be placed)
  • -No space to place the device (as judged by the health care practitioner placing the device)
  • -Dexamethasone is given as antenatal corticosteroid instead of Betamethasone

研究者

相似试验